Articles related to Family Medicine/General Practice

A network meta-analysis of 32 randomized trials found long-term, high-dose vitamin D supplementation added to standard multiple sclerosis therapy reduced relapse risk and eased disability progression, while short-term use showed no significant effect.

A BMJ systematic review of 69 trials found calcium and vitamin D supplementation provided little to no reduction in fracture or fall risk among nearly 154,000 older adults studied.

The FDA has approved the first generic version of baloxavir marboxil, a single-dose influenza antiviral noninferior to oseltamivir, ahead of the 2026-2027 flu season.

Past-year creatine use among U.S. adolescents roughly doubled between 2019 and 2024, even as anabolic steroid use continued a two-decade decline, according to a national survey of nearly 875,000 students.

A resurgent social media challenge involving high-dose diphenhydramine ingestion has been linked to seizures, cardiac arrest, and adolescent deaths, with poison center calls more than doubling in the first half of 2026 compared with all of 2025.

A new Endocrine Society guideline favors watchful waiting over immediate evaluation for many girls with early breast development, narrows brain MRI and genetic testing to select cases, and sets age limits for stopping GnRH agonist therapy.